Genome-wide association studies (GWAS) have also identified polymorphisms in IL10 and IL10R genes, both associated with an early onset of IBD, a greater severity of disease, and a lack of response to conventional treatments, including anti-tumour necrosis factor (TNF) biologics therapy [19,20]. The gene discussed is IL10; the disease is inflammatory bowel disease.